Table 2.

Characteristics of SLE patients with Pneumocystis pneumonia.

Age	Sex	Race	P. jiroveciitestingmodality	Current daily prednisone dose (mg)*	Cumulative prednisone dose in previous 90 days (mg)*	Non-steroid immunosuppressants in previous 90 days*	HIV/ AIDS1	WBC* (cells/ μL)	Lymphocytes* (cells/μL)	CD4 count* (cells/ μL)
28	F	Black	PCR**	15	1,120	Azathioprine	No	6300	310	N/A
31	F	White	GMS***	30	3,250	None	No	2800	120	N/A
43	F	White	GMS***	0	0	None	Yes	1100	N/A	17
44	F	Black	GMS***	0	0	None	Yes	3300	550	104

N/A = not applicable, WBC = White blood cell, HIV/AIDS = Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome

^*Timing in relation to diagnosis of Pneumocystis jirovecii pneumonia diagnosis

^**Polymerase chain reaction

^***Gömöri methenamine silver